The 2024 ESC Guidelines for the management of atrial fibrillation (AF), developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS), introduce new approaches
READ MORE
The 2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Diseases (PAAD) approach these vascular conditions as interconnected components of the cardiovascular system, ac
READ MORE
According to a new study, the anti-obesity drug semaglutide may help prevent heart attacks and other major cardiac events in overweight individuals with cardiovascular disease, whether or not th
READ MORE
Researchers at Mass General Brigham found that women have a lower risk of developing postoperative atrial fibrillation (poAF) after surgery compared to men but face a higher risk of long-term mortali
READ MORE
A new study from the University of Georgia reveals that Type 2 diabetes surged by nearly 20% between 2012 and 2022. The research shows an increase in diabetes across all sociodemographic groups,...
READ MORE
In a recent study published in Engineering, a team of researchers revealed a significant correlation between stock market volatility and the risk of major adverse cardiovascular events (MACEs) and...
READ MORE
Clinicians typically use 12-lead electrocardiograms (ECGs) to diagnose heart conditions such as heart attacks and rhythm disturbances. These ECGs involve a complex arrangement of electrodes and wires
READ MORE
According to a new study, higher levels of urinary metals such as cadmium, tungsten, uranium, cobalt, copper, and zinc are associated with increased cardiovascular disease (CVD) and mortality. While...
READ MORE
Patients with congestive heart failure (CHF) who have impaired blood supply are at a higher risk of sudden cardiac death (SCD), with an estimated incidence of up to 22%. Current clinical gui
READ MORE
When it comes to treating cardiac arrest, swift action can be the crucial factor between life and death. Researchers from Osaka Metropolitan University have introduced a groundbre
READ MORE
![Medtronic Secures CE Mark for Innovative Pulmonary Valve Replacement System for Congenital Heart Disease"](https://res.cloudinary.com/healthmanagement-org/image/upload/c_thumb,f_auto,fl_lossy,h_100,q_90,w_100/v1736278991/cw/00129025_cw_image_wi_87dba3e3d5217851f249d0509c004718.webp "Medtronic Secures CE Mark for Innovative Pulmonary Valve Replacement System for Congenital Heart Disease"")
